Document is current
Any future updates will be listed below
-
Authors
Slim, Marleen A.
van Mourik, Niels
Bakkerus, Lieke
Fuller, Katherine
Acharya, Lydia
Giannidis, Tatiana
Dionne, Joanna C.
Oczkowski, Simon J. W.
Netea, Mihai G.
Pickkers, Peter
Giamarellos-Bourboulis, Evangelos J.
Müller, Marcella C. A.
van der Poll, Tom
Wiersinga, W. Joost
,
Kullberg, Bart-Jan
Nooijer, Aline
Veerdonk, Frank
Oever, Jaap
Hoogerwerf, Jacobien
Hulscher, Marlies
Netea, Mihai
Oerlemans, Anke
Ziogas, Athanasios
Swillens, Julie
Berg, Lisa
Bos, Nynke
Kox, Matthijs
Estratiou, Leda
Giamarellos-Bourboulis, Evangelos
Kotsaki, Antigoni
Nikolaos, Antonakos
Spyros, Gregoriadis
Calandra, Thierry
Meylan, Sylvain
Snaka, Tiia
Roger, Thierry
Bauer, Michael
Brunkhorst, Frank
Bloos, Frank
Weis, Sebastian
Hartman, Willy
Slim, Marleen
Vught, Lonneke
Vlaar, Alexander
Muller, Marcela
Wiersinga, Joost
Lupse, Mihaela
Santamarean, Grigore
Rimmele, Thomas
Conti, Filippo
Monneret, Guillaume
Aschenbrenner, Anna
Schultze, Joachim
Uelft, Martina
Bock, Christoph
terHorst, Robert
Gat-Viks, Irit
Ron, Einat
Yunkovitz, Gal
Ablott, Sophie
Peronnet, Estelle
Balezeaux, Margaux
Saliou, Adrien
Hart, Julie
Vlaar, Alexander P. J.
van Vught, Lonneke A.
-
Funding
Funding for this research was provided by:
Horizon 2020 (847422)
- License Information
-
More Information
Article History
Received: 13 March 2024
Accepted: 20 May 2024
First Online: 28 May 2024
Declarations
:
: Not applicable.
: Not applicable.
: SJWO has received travel support from Fisher & Paykel Healthcare. MGN is a scientific founder of TTxD, Lemba and Biotrip. PP has received travel reimbursements and consulting fees from AM-Pharma, Adrenomed, EBI Paion, Sphingotec, and 4Teen4. EJG-B has received honoraria from Abbott Products Operations AG, bioMérieux, Brahms GmbH, GSK, InflaRx GmbH, Sobi and Xbiotech Inc; independent educational grants from Abbott Products Operations, bioMérieux Inc, InflaRx GmbH, Johnson & Johnson, MSD, UCB, Swedish Orphan Biovitrum AB; and funding from the Horizon 2020 European Grants ImmunoSep and RISCinCOVID and the Horizon Health grant EPIC-CROWN-2 (granted to the Hellenic Institute for the Study of Sepsis). WJW reports a project grants from EU, Amsterdam UMC and NOW/ZonMW and receives ad hoc consulting fees from GSK, Pfizer, Sobi, AstraZeneca paid to the institution. APJV receives consultant fees from InflaRx paid to the institution. LAvV was supported by the <i>Netherlands Organisation</i> for <i>Health Research</i> and <i>Development</i> ZonMW (Nederlandse Organisatie voor Wetenschappelijk Onderzoek NWO) VENI grant 09150161910033.
